vs
Side-by-side financial comparison of CRYO CELL INTERNATIONAL INC (CCEL) and cbdMD, Inc. (YCBD). Click either name above to swap in a different company.
CRYO CELL INTERNATIONAL INC is the larger business by last-quarter revenue ($7.8M vs $5.0M, roughly 1.6× cbdMD, Inc.). cbdMD, Inc. runs the higher net margin — -5.6% vs -48.7%, a 43.0% gap on every dollar of revenue. On growth, cbdMD, Inc. posted the faster year-over-year revenue change (-1.9% vs -2.3%). CRYO CELL INTERNATIONAL INC produced more free cash flow last quarter ($1.2M vs $-977.3K). Over the past eight quarters, cbdMD, Inc.'s revenue compounded faster (7.1% CAGR vs -0.1%).
Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.
cbdMD, Inc. is a U.S.-based consumer wellness company that manufactures and distributes hemp-derived CBD products, including tinctures, topicals, gummies, pet care items, and bath products. All offerings undergo third-party quality testing, and are sold via e-commerce platforms, brick-and-mortar retail stores, and wellness partner channels primarily across the United States.
CCEL vs YCBD — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $7.8M | $5.0M |
| Net Profit | $-3.8M | $-283.1K |
| Gross Margin | 77.9% | 59.8% |
| Operating Margin | -50.6% | -5.7% |
| Net Margin | -48.7% | -5.6% |
| Revenue YoY | -2.3% | -1.9% |
| Net Profit YoY | -105.1% | -1975.7% |
| EPS (diluted) | $-0.46 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $7.8M | $5.0M | ||
| Q3 25 | $7.8M | $4.7M | ||
| Q2 25 | $7.9M | $4.6M | ||
| Q1 25 | $8.0M | $4.7M | ||
| Q4 24 | $8.0M | $5.1M | ||
| Q3 24 | $8.1M | $4.6M | ||
| Q2 24 | $8.0M | $5.2M | ||
| Q1 24 | $7.9M | $4.4M |
| Q4 25 | $-3.8M | $-283.1K | ||
| Q3 25 | $749.4K | $-680.0K | ||
| Q2 25 | $355.8K | $-895.3K | ||
| Q1 25 | $282.9K | $-480.8K | ||
| Q4 24 | $-1.9M | $15.1K | ||
| Q3 24 | $1.1M | $-152.8K | ||
| Q2 24 | $655.8K | $459.7K | ||
| Q1 24 | $556.2K | $-3.0M |
| Q4 25 | 77.9% | 59.8% | ||
| Q3 25 | 77.0% | 58.8% | ||
| Q2 25 | 76.6% | 61.5% | ||
| Q1 25 | 75.1% | 62.3% | ||
| Q4 24 | 78.4% | 66.5% | ||
| Q3 24 | 73.6% | 53.9% | ||
| Q2 24 | 74.8% | 65.8% | ||
| Q1 24 | 73.7% | 59.0% |
| Q4 25 | -50.6% | -5.7% | ||
| Q3 25 | 24.3% | -14.5% | ||
| Q2 25 | 18.8% | -19.6% | ||
| Q1 25 | 13.3% | -10.2% | ||
| Q4 24 | -1.5% | -1.7% | ||
| Q3 24 | 17.2% | -6.9% | ||
| Q2 24 | 17.3% | -7.4% | ||
| Q1 24 | 10.5% | -35.4% |
| Q4 25 | -48.7% | -5.6% | ||
| Q3 25 | 9.6% | -14.4% | ||
| Q2 25 | 4.5% | -19.4% | ||
| Q1 25 | 3.5% | -10.1% | ||
| Q4 24 | -23.2% | 0.3% | ||
| Q3 24 | 13.0% | -3.4% | ||
| Q2 24 | 8.2% | 8.9% | ||
| Q1 24 | 7.1% | -68.8% |
| Q4 25 | $-0.46 | — | ||
| Q3 25 | $0.09 | — | ||
| Q2 25 | $0.04 | — | ||
| Q1 25 | $0.03 | — | ||
| Q4 24 | $-0.23 | — | ||
| Q3 24 | $0.13 | — | ||
| Q2 24 | $0.08 | $-0.15 | ||
| Q1 24 | $0.07 | $-1.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.3M | $3.4M |
| Total DebtLower is stronger | $8.4M | — |
| Stockholders' EquityBook value | $-18.6M | $9.0M |
| Total Assets | $61.7M | $11.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.3M | $3.4M | ||
| Q3 25 | $3.2M | $2.3M | ||
| Q2 25 | $4.4M | $1.1M | ||
| Q1 25 | $3.5M | $1.8M | ||
| Q4 24 | $3.5M | $2.0M | ||
| Q3 24 | $2.1M | $2.5M | ||
| Q2 24 | $1.5M | $2.4M | ||
| Q1 24 | $979.6K | $2.1M |
| Q4 25 | $8.4M | — | ||
| Q3 25 | $8.4M | — | ||
| Q2 25 | $8.4M | — | ||
| Q1 25 | $8.5M | — | ||
| Q4 24 | $8.5M | — | ||
| Q3 24 | $8.5M | — | ||
| Q2 24 | $8.5M | — | ||
| Q1 24 | $8.6M | — |
| Q4 25 | $-18.6M | $9.0M | ||
| Q3 25 | $-14.8M | $7.2M | ||
| Q2 25 | $-15.6M | $6.1M | ||
| Q1 25 | $-14.7M | $665.8K | ||
| Q4 24 | $-13.2M | $1.8M | ||
| Q3 24 | $-9.6M | $2.0M | ||
| Q2 24 | $-10.7M | $3.0M | ||
| Q1 24 | $-10.3M | $3.1M |
| Q4 25 | $61.7M | $11.8M | ||
| Q3 25 | $63.2M | $10.4M | ||
| Q2 25 | $64.4M | $9.9M | ||
| Q1 25 | $64.4M | $10.9M | ||
| Q4 24 | $64.7M | $11.5M | ||
| Q3 24 | $62.9M | $10.6M | ||
| Q2 24 | $62.6M | $13.8M | ||
| Q1 24 | $61.7M | $14.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.3M | $-812.5K |
| Free Cash FlowOCF − Capex | $1.2M | $-977.3K |
| FCF MarginFCF / Revenue | 15.5% | -19.5% |
| Capex IntensityCapex / Revenue | 0.9% | 3.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $5.2M | $-2.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.3M | $-812.5K | ||
| Q3 25 | $2.5M | $-240.7K | ||
| Q2 25 | $707.0K | $-704.2K | ||
| Q1 25 | $954.1K | $-189.5K | ||
| Q4 24 | $2.2M | $-317.9K | ||
| Q3 24 | $2.4M | $167.4K | ||
| Q2 24 | $1.8M | $289.8K | ||
| Q1 24 | $-356.9K | $-704.1K |
| Q4 25 | $1.2M | $-977.3K | ||
| Q3 25 | $2.5M | $-243.6K | ||
| Q2 25 | $644.6K | $-705.7K | ||
| Q1 25 | $892.0K | $-205.0K | ||
| Q4 24 | $2.1M | $-482.3K | ||
| Q3 24 | $2.3M | $157.4K | ||
| Q2 24 | $21.5K | — | ||
| Q1 24 | $-814.6K | $-708.7K |
| Q4 25 | 15.5% | -19.5% | ||
| Q3 25 | 31.9% | -5.2% | ||
| Q2 25 | 8.1% | -15.3% | ||
| Q1 25 | 11.2% | -4.3% | ||
| Q4 24 | 26.8% | -9.4% | ||
| Q3 24 | 27.9% | 3.5% | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | -10.4% | -16.2% |
| Q4 25 | 0.9% | 3.3% | ||
| Q3 25 | 0.5% | 0.1% | ||
| Q2 25 | 0.8% | 0.0% | ||
| Q1 25 | 0.8% | 0.3% | ||
| Q4 24 | 0.1% | 3.2% | ||
| Q3 24 | 2.3% | 0.2% | ||
| Q2 24 | 21.8% | 0.0% | ||
| Q1 24 | 5.8% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | 3.38× | — | ||
| Q2 25 | 1.99× | — | ||
| Q1 25 | 3.37× | — | ||
| Q4 24 | — | -21.06× | ||
| Q3 24 | 2.32× | — | ||
| Q2 24 | 2.70× | 0.63× | ||
| Q1 24 | -0.64× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCEL
Segment breakdown not available.
YCBD
| Sales Channel Directly To Consumer | $3.6M | 72% |
| Sales Channel Through Intermediary | $1.4M | 28% |
